March 03, 2021
BioAge, in a recent press release, has announced the start of its phase 2a clinical trial in elderly patients with unexplained anemia of aging. BioAge is a California-based company founded in 2015 with a very direct focus on aging. It utilizes a systems biology approach and AI-based drug discovery platform to target important pathways which...